Lalit Baregama, PhD, is an accomplished professional in global sales and business development within the pharmaceutical industry, currently serving as Chief Business Officer at Symbiotec Pharmalab Pvt. Ltd. since April 2024. Previously, Lalit held the position of Chief Growth Officer at Morepen Laboratories Limited India, overseeing sales for APIs and intermediates, and also served as Vice President for Global Sales and Business Development. Experience includes leadership roles at Viwit Pharmaceuticals, Cadila Pharmaceuticals Limited, and Vimta Labs Ltd, focusing on strategic planning, project management, and international business development. Lalit's early career includes significant contributions at Syngeny PharmaTech, Western Drugs Ltd, Hikal Ltd, WuXi AppTec, and Ranbaxy, with a foundation in medicinal chemistry from Mohanlal Sukhadia University, where Lalit earned a PhD.